These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36399352)

  • 1. Association of Project ECHO Training With Buprenorphine Prescribing by Primary Care Clinicians in Minnesota for Treating Opioid Use Disorder.
    Solmeyer AR; Berger AT; Barton SL; Nguyen B; Bart GB; Grahan B; Bell HJ; DeVine KM; Merrick W
    JAMA Health Forum; 2022 Nov; 3(11):e224149. PubMed ID: 36399352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine Prescribing and Challenges Faced Among National Health Service Corps Clinicians.
    Rowan K; Shah SV; Binns S; Murphy E; Satorius J; Ghobadi A; Krauss D; Robbins C; Schoebel V; Knudson A; Kepley H;
    JAMA Netw Open; 2024 May; 7(5):e2411742. PubMed ID: 38758556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full agonist opioid prescribing by primary care clinicians after buprenorphine training.
    Gadomski A; Anderson J; Chung YK; Krupa N; Jenkins P
    Subst Abus; 2022; 43(1):69-75. PubMed ID: 32150525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?
    Grove LR; Rao N; Domino ME
    Addiction; 2022 Nov; 117(11):2855-2863. PubMed ID: 35194878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and Prescribing Patterns of Clinicians Waivered to Prescribe Buprenorphine for Opioid Use Disorder Before and After Release of New Practice Guidelines.
    Jones CM; Olsen Y; Ali MM; Sherry TB; Mcaninch J; Creedon T; Juliana P; Jacobus-Kantor L; Baillieu R; Diallo MM; Thomas A; Gandotra N; Sokolowska M; Ling S; Compton W
    JAMA Health Forum; 2023 Jul; 4(7):e231982. PubMed ID: 37477926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are x-waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x-waiver trainings.
    Gordon AJ; Kenny M; Dungan M; Gustavson AM; Kelley AT; Jones AL; Hawkins E; Frank JW; Danner A; Liberto J; Hagedorn H
    Am J Addict; 2022 Mar; 31(2):152-158. PubMed ID: 35118756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine Waiver Attitudes Among Primary Care Providers.
    Lai B; Croghan I; Ebbert JO
    J Prim Care Community Health; 2022; 13():21501319221112272. PubMed ID: 35822763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver.
    Lanham HJ; Papac J; Olmos DI; Heydemann EL; Simonetti N; Schmidt S; Potter JS
    JAMA Netw Open; 2022 May; 5(5):e2212419. PubMed ID: 35552721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US.
    Franz B; Dhanani LY; Hall OT; Brook DL; Simon JE; Miller WC
    Harm Reduct J; 2023 Dec; 20(1):180. PubMed ID: 38129903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomes.
    Anderson JB; Martin SA; Gadomski A; Krupa N; Mullin D; Cahill A; Jenkins P
    Subst Abus; 2022; 43(1):222-230. PubMed ID: 34086529
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of MOUD ECHO Participation on Expansion of Buprenorphine Prescribing in Rural Primary Care.
    Salvador JG; Myers OB; Bhatt SR; Jacobsohn V; Lindsey L; Alkhafaji RS; Rishel Brakey H; Sussman AL
    Subst Abus; 2023 Oct; 44(4):282-291. PubMed ID: 37902036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements.
    Christine PJ; Chahine RA; Kimmel SD; Mack N; Douglas C; Stopka TJ; Calver K; Fanucchi LC; Slavova S; Lofwall M; Feaster DJ; Lyons M; Ezell J; Larochelle MR
    JAMA Netw Open; 2024 Aug; 7(8):e2425999. PubMed ID: 39102264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empowering Psychiatric Mental Health Nurse Practitioners to Expand Treatment Opportunities for Veterans With Opioid Use Disorder.
    Jones J; Tierney M; Jacobs G; Chien SY; Mallisham S
    J Addict Nurs; 2020; 31(4):261-268. PubMed ID: 33264198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic.
    Jones CM; Diallo MM; Vythilingam M; Schier JG; Eisenstat M; Compton WM
    Drug Alcohol Depend; 2021 Aug; 225():108783. PubMed ID: 34049102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of barriers and facilitators to the adoption of buprenorphine prescribing after implementation of a New Jersey-wide incentivized DATA-2000 waiver training program.
    Nyaku AN; Zerbo EA; Chen C; Milano N; Johnston B; Chadwick R; Marcello S; Baston K; Haroz R; Crystal S
    BMC Health Serv Res; 2024 Feb; 24(1):179. PubMed ID: 38331802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
    Rhee TG; Rosenheck RA
    Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of Buprenorphine in the Emergency Department: A Survey of Emergency Clinicians.
    Barkley A; Lander L; Dilcher B; Tuscano M
    West J Emerg Med; 2024 Jul; 25(4):470-476. PubMed ID: 39028232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to Buprenorphine Prescribing for Opioid Use Disorder in Hospice and Palliative Care.
    Janet Ho J; Jones KF; Sager Z; Neale K; Childers JW; Loggers E; Merlin JS
    J Pain Symptom Manage; 2022 Aug; 64(2):119-127. PubMed ID: 35561938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of a Multimodal Educational Intervention for Primary Care Physicians With Prescriptions of Buprenorphine for Opioid Use Disorders.
    Clark B; Kai M; Dix R; White J; Rozenfeld Y; Levy S; Engstrom K
    JAMA Netw Open; 2019 Oct; 2(10):e1913818. PubMed ID: 31642929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.